Abbott   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Lake Bluff IL United States (1888)
Status: Left NME R&D (2013)

Organization Overview

First Clinical Trial
1991
NCT00600769
First Marketed Drug
1946
trimethadione (tridione)
First NDA Approval
1946
trimethadione (tridione)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Abbott | ABBOTT | Abbott Biologicals | Abbott Biotherapeutics Corp. | Abbott (China) | Abbott Diabetes Care | Abbott Diagnostics Division | Abbott Germany, Medical Department | Abbott Healthcare Products BV | Abbott Healthcare Products B.V | Abbott Healthcare Products B.V. | Abbott India Ltd. | Abbott Japan | Abbott Japan Co.,Ltd | Abbott Laboratories, Poland | Abbott Laboratories - Saudi Arabia | Abbott Laboratories S.A., Ukraine | ABBOTT LABS | Abbott Labs PPD R&D | Abbott Medical Devices | Abbott Medical Devices Neuromodulation | Abbott Medical Optics | Abbott Northwestern Hospital | Abbott Nutrition | Abbott Nutrition Research & Development | Abbott Products | Abbott Rapid Dx | Abbott Vascular | Clinical Program Director | GynoPharm | Minneapolis Heart / Abbott Northwestern | Recalcine (GynoPharm) | Renal Global Project Team, Abbott Laboratories | ROSS LABS | Ross Products | Ross Products Division of Abbott Laboratories